•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A01163 Summary:

BILL NOA01163
 
SAME ASNo Same As
 
SPONSORMcDonald
 
COSPNSR
 
MLTSPNSR
 
Amd §6810, Ed L
 
Requires the consent of the patient or an authorized individual to consent on the patient's behalf before a prescription is delivered.
Go to top    

A01163 Actions:

BILL NOA01163
 
01/13/2023referred to higher education
01/03/2024referred to higher education
Go to top

A01163 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A1163
 
SPONSOR: McDonald
  TITLE OF BILL: An act to amend the education law, in relation to requiring the consent of the patient or an authorized individual to consent on the patient's behalf before a prescription is delivered   PURPOSE OR GENERAL IDEA OF BILL: To reduce medication waste and improve patient compliance and adherence by prohibiting pharmacies from automatically delivering prescriptions to patients without their consent or an individual authorized on the patient's behalf.   SUMMARY OF SPECIFIC PROVISIONS: Section 1 amends subdivision 2 of section 6810 of the education law, as added by chapter 881 of the laws of 1972, requiring that a pharmacy registered with the department pursuant to section sixty-eight hundred eight of the education law may not deliver a new or refilled prescription without the consent of the patient or an individual author- ized to consent on the patient's behalf. Consent shall include one of the following: (1) the patient or authorized individual's signature of acceptance of each prescription delivered; (2) the pharmacy may contact the patient or other authorized individual for consent to deliver and must document consent in the patient record; or (3) for pharmacies that administer refill reminder or medication adher- ence programs and deliver off premises, if a signature is not received on each prescription, then the refill reminder program or medication adherence program shall be an OPT-IN program that is updated with patient consent every 180 days accompanied by a documented patient record review by a licensed pharmacist from the providing pharmacy and the patient before continuation of medication delivery can occur. Pharmacy providers who deliver medication without patient or authorized individual consent will be required to accept the return of the medica- tion from the patient, provide that patient credit for any charges they may have paid, and will be required to destroy those medications sent without consent on delivery in accordance with applicable state and federal law. Nothing in this section shall be deemed to interfere with the requirements for refill reminder or medication adherence programs. Nothing in this section is intended to apply to long-term care pharmacy dispensing and delivery. Section 2 provides effective date.   JUSTIFICATION: The intent of this bill is to reduce medication waste, control cost, provide consumer protection and improve patient compliance by prohibit- ing pharmacies from automatically delivering new or refilled prescription medications to patients without their consent or the consent of an authorized individual on their behalf. Prescription medications, when taken appropriately under the supervision of a prescriber and consultation with a pharmacist, can be safe and effective. Unfortunately, as the utilization of prescription drugs has grown, medication waste has also increased both statewide and nationally. As excessive medication quantities accumulate in households they can fall into the wrong hands and lead to medical emergencies and even death and/or consequences that are tragic, avoidable and costly. Furthermore, excessive supplies of prescription products can easily cause patients to become confused, take the wrong medication, or take it incorrectly. Medication errors such as these translate directly into impaired health, therapy failures and increased hospitalizations. Discussion of medication waste is becoming more prevalent and a signif- icant discussion in public policy circles. In the Centers for Medicare & Medicaid Services (CMS) call letter dated April 1, 2013 sent to Medicare Advantage plans stated the following, "We received a number of comments that indicate beneficiaries return large quantities of unneeded medica- tions to community pharmacies for take-back programs because they were unable to stop auto-ship refill programs." This has led to consideration of a new CMS policy designed to cut waste and save taxpayer dollars by prohibition of auto-filling of prescriptions at the national level with federally funded Medicare Part D Plans. This is sound public policy that keeps the consumer in charge. It is a model that should be enacted at the state level. The United States Drug Enforcement Administration's National Prescription Drug Take-Back Initiative, which is aimed at providing a safe, convenient, and responsible means of disposing of prescription drugs, has taken back nearly three million pounds of unused and expired medications as a result of six nationwide take-back events. Addi- tionally, the National Pharmacy Community Pharmacists Association "Dispose my Meds" program has netted more than 150,000 lbs. of unused or expired non-controlled prescription medications. Pharmacies participat- ing in take-back programs in New York have taken back very costly medi- cations from people in their communities including one pharmacy in upstate New York that had taken back more than $125,000 of unused medi- cations from just three patients of which the prescriptions were paid for by federal, state and local taxpayers. Hundreds of such examples exist. Excessive supplies of prescription drugs in homes represent a waste of taxpayer dollars, an opportunity for diversion and misuse, and the potential for real patient harm.   PRIOR LEGISLATIVE HISTORY: 2019-2020: A.7555 2021-2022: A.3083   FISCAL IMPLICATIONS: None to the State   EFFECTIVE DATE: This bill shall take effect immediately.
Go to top

A01163 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          1163
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 13, 2023
                                       ___________
 
        Introduced by M. of A. McDONALD -- read once and referred to the Commit-
          tee on Higher Education
 
        AN  ACT to amend the education law, in relation to requiring the consent
          of the patient or an authorized individual to consent on the patient's
          behalf before a prescription is delivered

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subdivision  2  of  section 6810 of the education law, as
     2  amended by chapter 413 of the laws  of  2014,  the  second  undesignated
     3  paragraph  of paragraph (a) as amended by section 7 of part A of chapter
     4  57 of the laws of 2015, is amended to read as follows:
     5    2. (a) A prescription may not be refilled unless it bears  a  contrary
     6  instruction  and  indicates  on  its  face the number of times it may be
     7  refilled. A prescription may not be refilled more times than allowed  on
     8  the  prescription.  The  date of each refilling must be indicated on the
     9  original prescription. Prescriptions for controlled substances shall  be
    10  refilled only pursuant to article thirty-three of the public health law.
    11    A  pharmacy  registered with the department pursuant to section sixty-
    12  eight hundred eight or sixty-eight hundred eight-b of this  article  may
    13  not  deliver  a  new  or  refilled prescription off premises without the
    14  express consent of the patient or an individual authorized to consent on
    15  the patient's behalf or action taken in lieu of indicating  the  express
    16  consent of the patient to receive the prescription.  For the purposes of
    17  this  section,  express  consent [may be obtained in the same manner and
    18  process by which consent is deemed acceptable under the federal Medicare
    19  Part D program] shall include at least one of the following:
    20    (1) the patient or  authorized  individual's  physical  or  electronic
    21  signature authorizing each prescription delivered;
    22    (2)  the pharmacy may contact the patient or authorized individual for
    23  verbal, electronic or written  consent  to  deliver  and  must  document
    24  consent in the patient record; or
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02562-01-3

        A. 1163                             2
 
     1    (3)  for  pharmacies  that  administer  refill  reminder or medication
     2  adherence programs and deliver off premises, if an  express  consent  is
     3  not  received  on each prescription, then the refill reminder program or
     4  medication adherence program shall be an OPT-IN program that is  updated
     5  as to patient consent every one hundred eighty days.
     6    (b)  Pharmacy  providers  who  deliver  medication  without patient or
     7  authorized individual express consent will be  required  to  accept  the
     8  return  of  the medication from the patient, provide that patient credit
     9  for any charges they may have paid, provide credit to the  medical  plan
    10  for charges paid, and will be required to destroy those medications sent
    11  without  consent  on  delivery  in  accordance with applicable state and
    12  federal law. Nothing in this section shall be deemed to  interfere  with
    13  the  requirements  for refill reminder or medication adherence programs.
    14  Nothing in this section is intended to apply to long-term care  pharmacy
    15  dispensing and delivery.
    16    (c)  Pharmacy providers who deliver medications shall provide a state-
    17  ment of rights upon delivery  on  an  annual  basis  that  outlines  the
    18  patient's rights regarding consent and prescription delivery options.
    19    § 2. This act shall take effect immediately.
Go to top